Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

SMS Lifesciences India Ltd - 540679 - Board Meeting Intimation for 86Th Board Meeting (08.08.2023)

 SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2023 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2023, Board Report for the year 2022-23 and fixing the date for 17th Annual General Meeting, along with any other items as may be decided by the Board of Directors.
02-08-2023
Bigul

SMS Lifesciences India Ltd - 540679 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Compliances Certificate
11-07-2023
Bigul

SMS Lifesciences India Ltd - 540679 - Closure of Trading Window

 Intimation of Trading Window Closure
28-06-2023
Bigul

SMS Lifesciences India Ltd - 540679 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hari Kishore Potluri
22-06-2023
Bigul

SMS Lifesciences India Ltd - 540679 - Violation Report (Insider Trading Code)

 Violation report pertaining to Clause 13 of Schedule B & Regulation 9 of the SEBI (Prohibition of Insider Trading) Regulations 2015 read along with SEBI Circular no. SEBI/HO/ISD/ISD/CIR/P /2020/135 dated July 23, 2020.
02-06-2023
Bigul

SMS Lifesciences India Ltd - 540679 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 Enclosed is the web link to the Code of Conduct and various other policies under PIT Regulations.
31-05-2023
Bigul

SMS Lifesciences India Ltd - 540679 - Newspaper Publication (Financial Results)

 Enclosed are copies of the newspaper advertisement.
31-05-2023
Bigul

SMS Lifesciences India Ltd - 540679 - Update On Material Subsidiary

 Board of Directors of M/s Mahi Drugs Private Limited (subsidiary Company/ Mahi Drugs) at its Meeting held on May 29, 2023, has approved the reappointment of M/s. Rambabu & Co, Chartered Accountants, Hyderabad as the Statutory Auditors of the subsidiary Company to hold office for a further period of 5 (five) years till the conclusion of the Annual General Meeting (AGM) to be held in the year 2028, subject to the approval of Shareholders of Mahi Drugs in the ensuing general meeting.
30-05-2023
Bigul

SMS Lifesciences India Ltd - 540679 - Reappointment Of Auditor(S)

 Secretarial Auditor and Cost Auditor are reappointed for the year 2023-24.
30-05-2023
Bigul

Annual report for SMS Lifesciences India Ltd. for FY-2023
30-05-2023
Next Page
Close

Let's Open Free Demat Account